Registered Owners
- View profile →
FONKO INTERNATIONAL PHARMACEUTICALS - INDONESIA
KAB. BEKASI
NPWP: 312735350413000
owner
Direktorat Registrasi ObatValid
FONTREXED
- BPOM Number
- DKL2041501144B1
- Approved
- 30 March 2026
- Expiry
- 15 January 2031
- Form
- SERBUK INJEKSI LIOFILISASI
About This Registration
FONTREXED is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKL2041501144B1. Its current registration status is Valid, with the licence valid until 15 January 2031. The product is registered to FONKO INTERNATIONAL PHARMACEUTICALS - INDONESIA. BPOM first approved this registration in January 2026. All registration data is sourced directly from the official BPOM public database and updated daily.
Registration Details
- Application
- newaero
- Packaging
- DUS, 1 VIAL @ 100 MG
- Department
- Direktorat Registrasi Obat
Retail Audit Service
Get detailed market intelligence for this product across Indonesian retail channels
Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?
Stock availability and positioning verification
Price checking and competitor analysis
Display quality and promotional material assessment
Store condition and customer experience evaluation
Custom questions tailored to your research needs
Professional photographs and detailed reports
Manufacturing Sites
- View profile →
FONKO INTERNATIONAL PHARMACEUTICALS - INDONESIA
KAB. BEKASI
primary
Ingredients (1)
PEMETREXED DISODIUM HEMIPENTAHYDRATE
Market Intelligence
- Owner Portfolio
- FONKO INTERNATIONAL PHARMACEUTICALS - INDONESIA holds 17 BPOM registrations
- Manufacturer Scale
- FONKO INTERNATIONAL PHARMACEUTICALS - INDONESIA produces 17 registered products
- Registration Age
- Registered for 6 months
Is this your product?
Claim it to manage registration, track renewals, and get expiry alerts.